Relationship between epigenetic and metabolic alterations in castration-resistant prostate cancer

被引：0
|
作者：
Kanesaka, Manato [1 ,2 ]
Sato, Hiroaki [2 ]
Hoshii, Takayuki [1 ]
Okabe, Atsushi [1 ]
Fukuyo, Masaki [1 ]
Nawai, Bahityar R. [1 ]
Sakamoto, Shinichi [2 ]
Komiya, Akira [2 ]
Ichikawa, Tomohiko [2 ]
Kaneda, Atsushi [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Mol Oncol, Chiba, Japan
[2] Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P14-31-3
引用
收藏
页码：1592 / 1592
页数：1
相关论文
共 50 条
  • [21] Corticotherapy in castration-resistant prostate cancer
    Lebdai, S.
    Branchereau, J.
    Robert, G.
    De La Tallie, A.
    Bouchaert, P.
    PROGRES EN UROLOGIE, 2013, 23 : S23 - S33
  • [22] Enzalutamide in Castration-Resistant Prostate Cancer
    Anker, Markus S.
    Lehmann, Lorenz H.
    Anker, Stefan D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1380 - 1380
  • [23] Nonmetastatic Castration-Resistant Prostate Cancer
    Hong, Jun Hyuk
    Kim, Isaac Y.
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (03) : 153 - 160
  • [24] Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer
    Ferrari, Anna C.
    Alumkal, Joshi J.
    Stein, Mark N.
    Taplin, Mary-Ellen
    Babb, James
    Barnett, Ethan S.
    Gomez-Pinillos, Alejandro
    Liu, Xiaomei
    Moore, Dirk
    DiPaola, Robert
    Beer, Tomasz M.
    CLINICAL CANCER RESEARCH, 2019, 25 (01) : 52 - 63
  • [25] Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone
    Conteduca, Vincenza
    Caffo, Orazio
    Derosa, Lisa
    Veccia, Antonello
    Petracci, Elisabetta
    Chiuri, Vincenzo Emanuele
    Santoni, Matteo
    Santini, Daniele
    Fratino, Lucia
    Maines, Francesca
    Testoni, Sara
    De Giorgi, Ugo
    PROSTATE, 2015, 75 (12): : 1329 - 1338
  • [26] Metabolic Reprogramming of Castration-Resistant Prostate Cancer Cells as a Response to Chemotherapy
    Petrella, Greta
    Corsi, Francesca
    Ciufolini, Giorgia
    Germini, Sveva
    Capradossi, Francesco
    Pelliccia, Andrea
    Torino, Francesco
    Ghibelli, Lina
    Cicero, Daniel Oscar
    METABOLITES, 2023, 13 (01)
  • [27] Epigenetic alterations in the multifaceted inhibitory effects of metformin on castration resistant prostate cancer
    Li, Xin
    Wei, Juncheng
    Matsumura, Satoko
    Guo, Yuqi
    Yuan, Huawei
    CANCER RESEARCH, 2014, 74 (19)
  • [28] Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer
    Sonpavde, Guru
    Agarwal, Neeraj
    Pond, Gregory Russell
    Nagy, Rebecca J.
    Nussenzveig, Roberto H.
    Hahn, Andrew W.
    Sartor, Oliver
    Gourdin, Theodore Stewart
    Nandagopal, Lakshminarayanan
    Ledet, Elisa M.
    Naik, Gurudatta
    Armstrong, Andrew J.
    Wang, Jue
    Bilen, Mehmet Asim
    Gupta, Shilpa
    Grivas, Petros
    Pal, Sumanta K.
    Lanman, Richard B.
    Talasaz, AmirAli
    Lilly, Michael B.
    CANCER, 2019, 125 (09) : 1459 - 1469
  • [29] Alterations of androgen action in castration-resistant prostate cancer (CRPC) and in abnormalities of virilization
    McPhaul, Michael J.
    Malewska, Alicia
    Vilaythong, Jill
    Glickman, Stephen E.
    Marcelli, Marco
    Sharifi, Nima
    Auchus, Richard J.
    ENDOCRINE JOURNAL, 2010, 57 : S264 - S264
  • [30] Correlation between genomic alterations and germline mutations in men with metastatic castration-resistant prostate cancer (mCRPC)
    Llacer Perez, C.
    Oliva Fernandez, L.
    Canada-Higueras, E.
    Saez, M. I.
    Villatoro, R.
    Montesa Pino, A.
    Herrera Imbroda, B.
    Hernandez, D.
    Lozano Mejorada, R.
    Romero Laorden, N.
    Marquez, M.
    Grau, G.
    Pineda, A.
    Lopez, F. J.
    Peinado, P.
    Alameda, D.
    Olmos, D.
    Castro, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S641 - S642
12345